Modeling complex neuropsychiatric disorders with human induced pluripotent stem cells

Current Opinion in Pharmacology

Volumn 11, Issue 5, 2011, Pages 521-527

  Tobe, Brian T D ^a,b   Snyder, Evan Y ^a   Nye, Jeffrey S ^c  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL STRESS; CLASSIFICATION; DISEASE MODEL; ENVIRONMENTAL FACTOR; GENE EXPRESSION; HEREDITY; HUMAN; HUMAN CELL; MENTAL DISEASE; NERVE CELL; NEURITE; PERIKARYON; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; SYNAPSE;

EID: 80053120148     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2011.05.007     Document Type: Review

References (33)

1. E.J. Nestler, and S.E. Hyman Animal models of neuropsychiatric disorders Nat Neurosci 13 2010 1161 1169
2. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872 (Pubitemid 350138099)
3. I.H. Park, N. Arora, H. Huo, N. Maherali, T. Ahfeldt, A. Shimamura, M.W. Lensch, C. Cowan, K. Hochedlinger, and G.Q. Daley Disease-specific induced pluripotent stem cells Cell 134 2008 877 886
4. T. Vierbuchen, A. Ostermeier, Z.P. Pang, Y. Kokubu, T.C. Sudhof, and M. Wernig Direct conversion of fibroblasts to functional neurons by defined factors Nature 463 2010 1035 1041
5. J. Kim, J.A. Efe, S. Zhu, M. Talantova, X. Yuan, S. Wang, S.A. Lipton, K. Zhang, and S. Ding Direct reprogramming of mouse fibroblasts to neural progenitors Proc Natl Acad Sci USA 108 2011 7838 7843
6. K.S. Kim, H.J. Lee, H.S. Jeong, J. Li, Y.D. Teng, R.L. Sidman, E.Y. Snyder, and S.U. Kim Self-renewal induced efficiently, safely, and effective therapeutically with one regulatable gene in a human somatic progenitor cell Proc Natl Acad Sci USA 108 2011 4876 4881
7. V.B. Mattis, and C.N. Svendsen Induced pluripotent stem cells: a new revolution for clinical neurology? Lancet Neurol 10 2011 383 394
8. G. Hargus, O. Cooper, M. Deleidi, A. Levy, K. Lee, E. Marlow, A. Yow, F. Soldner, D. Hockemeyer, and P.J. Hallett Differentiated parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in parkinsonian rats Proc Natl Acad Sci USA 107 2010 15921 15926
9. A.D. Ebert, J. Yu, F.F. Rose Jr., V.B. Mattis, C.L. Lorson, J.A. Thomson, and C.N. Svendsen Induced pluripotent stem cells from a spinal muscular atrophy patient Nature 457 2009 277 280
10. G. Lee, E.P. Papapetrou, H. Kim, S.M. Chambers, M.J. Tomishima, C.A. Fasano, Y.M. Ganat, J. Menon, F. Shimizu, and A. Viale Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs Nature 461 2009 402 406
11. A.R. Muotri, M.C. Marchetto, N.G. Coufal, R. Oefner, G. Yeo, K. Nakashima, and F.H. Gage L1 retrotransposition in neurons is modulated by mecp2 Nature 468 2010 443 446
12. M.C. Marchetto, C. Carromeu, A. Acab, D. Yu, G.W. Yeo, Y. Mu, G. Chen, F.H. Gage, and A.R. Muotri A model for neural development and treatment of rett syndrome using human induced pluripotent stem cells Cell 143 2010 527 539
13. F. Soldner, D. Hockemeyer, C. Beard, Q. Gao, G.W. Bell, E.G. Cook, G. Hargus, A. Blak, O. Cooper, and M. Mitalipova Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors Cell 136 2009 964 977
14. H.N. Nguyen, B. Byers, B. Cord, A. Shcheglovitov, J. Byrne, P. Gujar, K. Kee, B. Schule, R.E. Dolmetsch, and W. Langston Lrrk2 mutant ipsc-derived da neurons demonstrate increased susceptibility to oxidative stress Cell Stem Cell 8 2011 267 280
15. P. Seibler, J. Graziotto, H. Jeong, F. Simunovic, C. Klein, and D. Krainc Mitochondrial parkin recruitment is impaired in neurons derived from mutant pink1 induced pluripotent stem cells J Neurosci 31 2011 5970 5976
16. K.J. Brennand, A. Simone, J. Jou, C. Gelboin-Burkhart, N. Tran, S. Sangar, Y. Li, Y. Mu, G. Chen, and D. Yu Modelling schizophrenia using human induced pluripotent stem cells Nature 473 2011 221 225
17. C.H. Chiang, Y. Su, Z. Wen, N. Yoritomo, C.A. Ross, R.L. Margolis, H. Song, and G.L. Ming Integration-free induced pluripotent stem cells derived from schizophrenia patients with a disc1 mutation Mol Psychiatry 16 2011 358 360
18. J. Huang, R.H. Perlis, P.H. Lee, A.J. Rush, M. Fava, G.S. Sachs, J. Lieberman, S.P. Hamilton, P. Sullivan, and P. Sklar Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression Am J Psychiatry 167 2010 1254 1263
19. K. Ishizuka, A. Kamiya, E.C. Oh, H. Kanki, S. Seshadri, J.F. Robinson, H. Murdoch, A.J. Dunlop, K.I. Kubo, and K. Furukori Disc1-dependent switch from progenitor proliferation to migration in the developing cortex Nature 473 2011 92 96
20. L.C. Laurent, I. Ulitsky, I. Slavin, H. Tran, A. Schork, R. Morey, C. Lynch, J.V. Harness, S. Lee, and M.J. Barrero Dynamic changes in the copy number of pluripotency and cell proliferation genes in human escs and ipscs during reprogramming and time in culture Cell Stem Cell 8 2011 106 118
21. M.F. Pera Stem cells: the dark side of induced pluripotency Nature 471 2011 46 47
22. N. Zhang, M.C. An, D. Montoro, and L.M. Ellerby Characterization of human huntington's disease cell model from induced pluripotent stem cells PLoS Curr 2 2010
23. S.J. Chamberlain, P.F. Chen, K.Y. Ng, F. Bourgois-Rocha, F. Lemtiri-Chlieh, E.S. Levine, and M. Lalande Induced pluripotent stem cell models of the genomic imprinting disorders angelman and prader-willi syndromes Proc Natl Acad Sci USA 107 2010 17668 17673
24. G.L. Boulting, E. Kiskinis, G.F. Croft, M.W. Amoroso, D.H. Oakley, B.J. Wainger, D.J. Williams, D.J. Kahler, M. Yamaki, and L. Davidow A functionally characterized test set of human induced pluripotent stem cells Nat Biotechnol 29 2011 279 286
25. Y. Mayshar, U. Ben-David, N. Lavon, J.C. Biancotti, B. Yakir, A.T. Clark, K. Plath, W.E. Lowry, and N. Benvenisty Identification and classification of chromosomal aberrations in human induced pluripotent stem cells Cell Stem Cell 7 2010 521 531
26. J.M. Polo, S. Liu, M.E. Figueroa, W. Kulalert, S. Eminli, K.Y. Tan, E. Apostolou, M. Stadtfeld, Y. Li, and T. Shioda Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells Nat Biotechnol 28 2010 848 855
27. K. Kim, A. Doi, B. Wen, K. Ng, R. Zhao, P. Cahan, J. Kim, M.J. Aryee, H. Ji, and L.I. Ehrlich Epigenetic memory in induced pluripotent stem cells Nature 467 2010 285 290
28. B.Y. Hu, J.P. Weick, J. Yu, L.X. Ma, X.Q. Zhang, J.A. Thomson, and S.C. Zhang Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency Proc Natl Acad Sci USA 107 2010 4335 4340
29. J.E. Kim, M.L. O'Sullivan, C.A. Sanchez, M. Hwang, M.A. Israel, K. Brennand, T.J. Deerinck, L.S. Goldstein, F.H. Gage, M.H. Ellisman, and A. Ghosh Investigating synapse formation and function using human pluripotent stem cell-derived neurons Proc Natl Acad Sci USA 108 2011 3005 3010
30. S.E. Howden, A. Gore, Z. Li, H.L. Fung, B.S. Nisler, J. Nie, G. Chen, B.E. McIntosh, D.R. Gulbranson, and N.R. Diol Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy Proc Natl Acad Sci USA 108 2011 6537 6542
31. T. Zhao, Z.N. Zhang, Z. Rong, and Y. Xu Immunogenicity of induced pluripotent stem cells Nature 474 2011 212 215
32. H. Inoue, and S. Yamanaka The use of induced pluripotent stem cells in drug development Clin Pharmacol Ther 89 2011 655 661
33. S.H. Yuan, J. Martin, J. Elia, J. Flippin, R.I. Paramban, M.P. Hefferan, J.G. Vidal, Y. Mu, R.L. Killian, and M.A. Israel Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells PLoS ONE 6 2011 e17540